NewHold Investment Corp. III shareholders approved the newcleo Business combination, with 19,986,437 votes in favor and 21,272,849 shares represented. The decision clears Shareholder approval for the proposed Merger structure, while completion remains subject to the agreement’s conditions and other stated transaction risks.
Key Highlights
- NewHold shareholders approved the business combination proposal by ordinary resolution.
- The merger proposal received 19,986,439 votes in favor.
- NewHold will become a Wholly Owned Subsidiary within the proposed newcleo transaction structure.
The business combination proposal received 19,986,437 votes in favor, while 21,272,849 ordinary shares were represented at the September 17 extraordinary general meeting.
Shareholders Approve Two Transaction Proposals
NewHold (NASDAQ: NHIC) had 27,612,763 ordinary shares eligible to vote as of the August 7 record date, and represented shares accounted for 77.04% of that total. The business combination proposal passed by ordinary resolution, with 1,286,410 votes against and two abstentions. Shareholders also approved the merger proposal by special resolution, recording 19,986,439 votes in favor and 1,286,410 against, with no abstentions. The approved business combination agreement is dated May 26 and covers NewHold, newcleo, newcleo1 Ltd. and newcleo2 Ltd. Under the planned structure, newcleo1 Ltd. would merge into NewHold, which would continue as the surviving company and become wholly owned by newcleo.
FAQs
Q: Did NewHold shareholders approve the newcleo business combination?
A: Yes. NewHold shareholders approved the business combination proposal by ordinary resolution, with 19,986,437 votes in favor and 1,286,410 against.
Q: What does NHIC shareholder approval allow?
A: NHIC shareholder approval allows the business combination agreement and merger proposal to proceed under the planned structure. NewHold would continue as the surviving company and become wholly owned by newcleo.
Q: Which entity survives the first NewHold merger?
A: NewHold would remain as the surviving company after newcleo1 Ltd. merges into it. NewHold would then become a wholly owned subsidiary of newcleo.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.